Friday, April 6, 2018

Incyte Shares Fall After Cancer Drug Fails in Trial With Merck's Keytruda

Incyte said its experimental cancer drug failed in a clinical trial that paired it with Merck’s Keytruda, striking a blow to combination therapies.

from WSJ.com: US Business https://ift.tt/2uQjdga
via IFTTT

No comments:

Post a Comment